Ito
This is Ito from the IR department of T&D Holdings. Thank you for joining our earnings call today.
The material is available on the group website under Investor Relations IR Events section. Today, I will go through the presentation for approximately 10 minutes, which will be followed by a Q&A session.
Let me start on page 3. First, I will explain the highlights of our second quarter results for the fiscal year ending in March 2027.
Group adjusted profit progressed steadily to reach ¥91.4 billion, representing 53.2% of our full-year forecast of ¥172 billion. Sales results of new policies increased year-on-year at Daido Life and T&D Financial Life.
While Taiyo Life sales declined year-on-year, it was in line with our full-year forecast. The surrender and lapse rate decreased at Daido Life and increased at Taiyo Life and T&D Financial Life.
The combined value of new business for the three life insurance companies was ¥83.7 billion against our full-year forecast of ¥172 billion. Group EV stood at ¥4 trillion and 399.7 billion, and the ESR was 227%.
Taiyo and Daido Life sold a combined net total of approximately ¥153 billion in domestic and foreign equities. In addition, the replacement of yen-denominated bonds in the first half will generate additional ¥4.5 billion approximately in annual interest income.
There is no change to our full-year earnings forecast. Please turn to the next page.
This is a breakdown of key financial results by company. Group adjusted profit increased year-on-year at all three life insurance companies and T&D United Capital.
Page 5 shows the breakdown of changes in group adjusted profit and the difference between group adjusted profit and net income. Please turn to page 6.
This slide presents key performance of the three life insurance companies. Adjusted profit increased year-on-year at all three life insurance companies.
Further detail on Taiyo and Daido's core profit is on page 7. At both companies, positive spread expanded due to an improvement in net investment income, boosting core profit.
Capital gains and losses at Taiyo and Daido remained slightly positive as gains on sales of shares were recorded, while losses on sales of bonds associated with portfolio rebalancing were recognized. Please turn to page 8.
At both Taiyo and Daido, the investment yield on core profit rose, widening the gap with the average assumed interest rate. As of the end of September 2026, the average assumed interest rates of Taiyo and Daido were 1.37% and 1.17% respectively.
Next page, please. T&D United Capital's adjusted profit increased by ¥11.1 billion year-on-year to ¥10.5 billion due to higher profit from Fortitude and a profit contribution from Viridios.
Please turn to page 11. I will now explain the sales results of the three life insurance companies.
Taiyo's key performance annualized premiums of new policies declined year-over-year due to lower sales in the agent channel, while sales through the sales representative channel exceeded the level of the same period last year. The surrender and lapse rate increased, mainly due to an increase in surrenders in the agent channel.
On the other hand, key performance annualized premiums for policies in force increased from the end of the previous fiscal year. Next page, please.
Daido's new policy amount increased year-on-year, driven mainly by its core term life insurance product. In addition, the surrender and lapse amounts decreased, and policy amount in force increased from the end of the previous fiscal year.
Please turn to the next page.
T&D Financial Life new policy amount increased year-on-year. The surrender and lapse rate increased, reflecting an increase in variable insurance policies that reached their target values in the first quarter.
However, the policy amount in force increased from the end of the previous fiscal year. Please turn to the next page.
Group EV increased by ¥161 billion from the previous fiscal year-end to ¥4 trillion, 399.7 billion, mainly driven by the accumulation of new business value and the rise in domestic and foreign stock prices. The value of new business for the three companies totaled ¥83.7 billion, and the new business margin was 9.4%.
Group EV change factors are provided on page 15, EV breakdown on page 16, EV sensitivity on page 17. Please turn to page 18.
This page shows the status of investments at Taiyo and Daido. Against our full-year plan to sell ¥160 billion in domestic and foreign equities, Taiyo and Daido have sold approximately ¥153 billion.
In addition, the replacement of yen-denominated bonds during the first half is expected to increase interest income by approximately ¥4.5 billion. The interest rate matching ratio is 99.9% for Taiyo and 92.4% for Daido.
Page 19 presents the status of foreign currency-denominated bonds, page 20 foreign currency-denominated assets, page 21 breakdown of foreign securities and others, pages 22 and 23 net valuation gains and losses on general account assets. Please turn to page 24.
As of the end of September, the ratio of strategic shareholdings against net assets rose to 19.8% from 19.1% at the previous fiscal year-end, reflecting an increase in the market value of the shares held. The total amount sold in the first half was ¥40.5 billion for the two companies combined.
We are making steady progress toward an intermediate target of reducing strategic shareholdings by 40% by March-end 2028 compared with March-end 2026. After October, we continued to sell, and the current ratio is below the end of the previous period.
We are also continuing to sell shares reclassified from strategic shareholdings to pure investment as part of our effort to reduce equity risk. As of September-end, approximately 65% of the cumulative total of ¥390 billion reclassified as pure investment had been sold.
Please turn to the next page. The ESR stood at 227% as of September-end, up 5 percentage points from the previous fiscal year.
The ESR increased as surplus grew from the previous fiscal year-end, while the increase in EC remained limited. Please turn to the next page.
There's no change to our full-year forecast. The breakdown for the three life insurance companies is provided on page 28.
For the six months for the third quarter onward, a ¥1 appreciation of the yen would have a negative impact of approximately ¥0.37 billion on group adjusted profit. This concludes our presentation on the financial results for the second quarter of fiscal March 2027.
We will now start the Q&A session.
Ito
Let me now introduce the first person to ask a question, Mr. Muraki of SMBC Nikko Securities.
Please go ahead and ask your question.
Muraki
Yes, this is Muraki from SMBC Nikko Securities. I have two questions.
My first question is about your investments in JGBs, or the yen-denominated bonds. On page 35, it showed Taiyo Life recorded around ¥30 billion in losses on bond sales in the first half, and Daido Life recorded just under ¥90 billion.
How should we think about losses on bond sales from the second half onward? Assuming early adoption could start as early as next fiscal year at the earliest for relaxation of the impairment rules, which is suggested in the media, would that change affect your actual investment decisions?
That is my first question on the yen-denominated bonds.
Ito
Thank you for your question, Mr. Muraki.
First, on bond portfolio rebalancing in the second half, our policy is to continue replacing bonds to improve the portfolio by raising yields and reducing risk. When deciding whether to carry out such bond replacements, we will take into account financial market conditions and how our earnings are tracking, among other factors, it is difficult at this point to give specific amounts or timing.
As for the early adoption of the treatment of the expected credit loss, or ECL, we are indeed considering adoption ahead of the mandatory date in FY 2030. However, we have yet to decide when to actually adopt that new standard.
As for where we stand today, we are in discussion with the audit firm on accounting policies and calculation methods. At the same time, we are preparing for adoption by developing calculation tools and putting operational processes in place.
If we decide to adopt the new standard, we would, of course, explain the impact and related matters in detail to investors at an IR briefing. Turning to how we think about the change in accounting treatment, as Mr.
Muraki, under the revised standard, even a sharp decline in bond prices due to rising interest rates would not, on its own, trigger impairment, as losses would be recognized based on credit risk. We believe this would bring the accounting treatment more closely in line with how life insurers actually invest with a view to holding assets over the long term.
Our current policy stands such that by clarifying our intent and ability to hold bonds to maturity, impairment is not required, and we therefore expect the accounting change to have limited impact. However, we do think it will give us more flexibility in managing our portfolio.
More flexibility does not mean more leeway, because when we replace policy reserve-matching bonds, that replacement must improve how the portfolio meets the requirements for that classification. In principle, we cannot simply swap one bond for another with the same maturity.
For bonds we have already declared we will hold to maturity, we currently confirm that we have neither a need nor an intention to sell them, no impairment is required, and we expect that treatment to continue under the revised standard. If circumstances change in a way we do not currently anticipate after the revised standard takes effect, we expect to discuss how to respond with our accounting auditor at that point, taking into account that a decline in market value alone would no longer trigger impairment.
That concludes my answer. Thank you.
Muraki
Thank you. My second question is about the overseas closed book business.
On page 38, the overall progress rate is around 40%, which seems a little bit slow, and earnings from alternative investments appear to have weakened further in the second quarter. At the first quarter briefing, you mentioned alternatives in Asia and Europe, as well as infrastructure fund.
What weighed on the second quarter results, and what is the drag? I imagine you already have some visibility into the third and the fourth quarter around the end of September, should we expect earnings from alternatives in the second half to be broadly in line with what we're seeing in the first half?
Ito
Yes, thank you for your question. First, looking at the overall profit for Fortitude, just looking at the second quarter, we are seeing some recovery.
As you noted, Mr. Muraki, earnings from alternative investments remained weak, but the variable annuity block performed better than expected.
The block is exposed to interest rate risk, surrender risk, and equity risk, which are hedged, but some basis risk and unhedgeable exposures inevitably remain, which worked in our favor for this quarter. Turning to alternatives and why they remained weak in Q2, I have to note that we recognize Fortitude's earnings with a three-month time lag, the results we picked up this quarter were Fortitude's earnings from April to June.
With alternatives, private equity in particular is marked to market using reports as of the end of the preceding quarter, the results we picked up this time were heavily influenced by equity market performance from January to March. The US market back then was relatively weak, and that was one of the reasons why the alternative earnings remained weak in the most recent quarter.
Following the first quarter, PE funds in Europe and Asia were also subdued, as well as the infrastructure investments. Looking ahead, alternatives are very investment-specific, which makes them hard to forecast, but the US equity market did recover to some extent from April to June, and that period matters for the results we will pick up in our third quarter.
Fortitude's results cover April through September, and its September valuation drew on US equity market levels at the end of June, we think we can expect some recovery in the valuation of the third quarter. From July to September, equity market in the US was reasonably solid, but the results depend heavily on the individual investments, it is difficult to say at this point.
Generally speaking, judging by how the US equity market has been moving, we believe earnings from alternatives are likely to show signs of recovery in the second half compared to the first half.
Muraki
That's very clear. Thank you very much for your response.
Let us move on to the next question. Tsuchino-san from BofA Securities, please go ahead with your question.
Tsuchino
I have two questions. First, I believe income gains from alternative investments at Taiyo and Daido were quite substantial.
Could you tell us how much income was generated through the second quarter, and what were the full-year plan? This time, upside from alternative investments have been offset by losses on the replacement of JGB.
Should we expect this pattern to continue in the second half? That is my first question.
My second question concerns insurance earnings. Although you do not disclose them separately, I believe your core profit excluding positive spread is approximately ¥45 billion for the three life insurance companies combined.
Based on my calculation, the figure has already reached approximately ¥35 billion. Could you explain what is driving this?
It would be helpful if you could provide a breakdown or explanation for each company.
Tsuchino-san, thank you for your question. Regarding your first question on alternative investments, unfortunately, under our disclosure policy, we are unable to provide the actual amounts.
I appreciate your understanding. What I can tell you is that in the first half, income from alternative investments exceeded half of our full-year budget by more than ¥18 billion.
Again, I apologize for not being able to disclose the actual figures, but alternative investment income for Taiyo and Daido combined was more than ¥18 billion above half of the full-year budget, performance has been very strong. Turning to insurance earnings, one factor common to both Taiyo and Daido is that operating expenses were lower than budgeted in the first half.
In addition, at Daido Life, death benefit payments were lower than expected, particularly in the first quarter. These factors have contributed to the strong progress.
By contrast, insurance earnings at T&D Financial Life have not progressed as strongly, the higher-than-expected earnings are mainly attributable to Taiyo and Daido. As for the outlook for the second half, it is highly likely that operating expenses that were not incurred in the first half will be incurred in the second half.
In other words, we do not expect insurance earnings in the second half to be as strong as in the first half. That said, death benefit payments at Daido were favorable in the first half.
With life expectancy generally increasing, there appears to be a broader trend toward lower death benefit payments. However, Daido Life has a relatively large number of high-value policies, results could fluctuate if we experience large insurance claims.
That concludes my response. Thank you.
Ito
We will now move on to the next question. Mr.
Watanabe from Daiwa Securities, please go ahead and ask your question.
Watanabe
Yes, this is Watanabe from Daiwa Securities. I have two questions.
My first question is about surrender rate. At Taiyo Life, have surrenders of Nagaiki My Kaigo policies increased recently?
At Daido Life's business briefing, you said that business conditions from SMEs were stable. Has that trend changed since then?
Ito
Yes, thank you for the question, Mr. Watanabe.
First, for Nagaiki My Life, surrenders remain stable at a low level. We will continue to monitor surrender trends as more policies recover their principal, but surrenders have remained stable at a low level through today, including the period since the end of September.
As for Daido Life, in the first quarter, we thought the impact of the new product launch last year would probably run its course, meaning the higher surrender due to new product launch would run its course, and that actually was what we saw in Q2. Meanwhile, surrenders due to difficulty in paying premiums continued to rise, but in terms of surrender amounts, we are below last fiscal year's level, for the full year, we expect surrenders to trend broadly in line with the plan.
Watanabe
Thank you. My second question is about capital policy.
Your ESR is above the upper end of the target range. Did you consider deploying excess capital this time, for example, through share buybacks?
Recently, I have an impression that appetite for acquiring life insurance companies are growing, could you tell us what measures, if any, you're considering to address what seems to be an excessively low valuation?
Ito
Yes, thank you for that question. Our ESR is currently 227%, but our basic approach is that we do not automatically return the portion above 225% to shareholders through share buybacks each quarter.
Also, the current 227% in our view is an appropriate range. Our mid- to long-term approach is to maintain a total payout ratio of 60%, and for the remaining 40%, we want to give priority to growth investment.
Based on that approach, we decided that we will not conduct any share buybacks this time. As for our view on the low valuation, what we can do is to improve the capital efficiency and steadily move forward to achieve our targets of ¥230 billion group adjusted profit and 15% ROE.
By achieving those targets, we want to improve how we are viewed in the market and raise the share price. Also, the way for us to improve is to steadily execute the targets laid out in the group long-term vision.
If you just look at the EV multiple, it's 0.5 times, but the valuation is not solely measured by EV multiple. We look at the price-to-earnings and dividend yield to measure our valuation and consider different options for capital policy.
Watanabe
I see. Thank you very much.
Let us move on to the next question. Sato-san from JPMorgan Securities, please go ahead with your question.
Sato
This is Sato from JPMorgan Securities. My first question, I would like to confirm some figures first.
Could you first share your planning assumptions regarding the scale of bond replacements, the associated capital losses, and the resulting improvement in interest income? If you were to use the upside in alternative investment income in the first half to absorb additional losses on bond replacements, how much additional improvement in interest income could potentially be achieved?
I appreciate your thoughts on this. That is my first question.
Thank you for your question, Sato-san. Unfortunately, we do not disclose our plans or the expected scale of bond replacements, I can share the actual results for the first half instead.
During the first half, Taiyo and Daido replaced approximately ¥250 billion worth of bonds in total. In terms of realized gains and losses on sales, the two companies recorded losses of just under ¥120 billion combined, as disclosed in our presentation materials.
As for the improvement in interest income, this is also disclosed in our materials. Bond replacements conducted during the first half generated an improvement of ¥4.5 billion.
These benefits from bond replacements accumulate over time. The improvement was ¥2.5 billion from replacements conducted in fiscal '24, ¥6.5 billion from last year, and ¥4.5 billion from the current first-half replacements.
These will add up to approximately ¥13.5 billion.
Sato
Understood. My second question concerns some recent developments in the financial markets, such as corporate bonds issued by neo-cloud companies and developments involving French government bonds.
Could you give us an indication of your exposure to these types of assets where risks appear to be increasing? Of course, if the exposure is negligible, that would be sufficient as an answer.
Thank you for your question, Sato-san. We do not disclose specific exposure amounts for individual assets, but you may understand that our exposure is negligible.
We recognize that credit markets are facing challenging conditions, partly due to persistently high interest rates in the US. However, we have not experienced any major problems with our investment funds to date.
In particular, we have not seen defaults exceeding our expectations or any credit events that would materially affect the soundness of our earnings. Our portfolio is well diversified, and we continue to manage our investments prudently.
Our diversification extends beyond individual issuers; we diversify across sectors, asset managers, and investment vintages as well. That concludes my response.
Sato
Just to confirm, does that mean the exposure is negligible, including Fortitude?
On Fortitude, I believe we touched on this at our previous results briefing. Its exposure to data centers and related AI infrastructure currently stands at $2 billion, representing around 2.5% of the investment portfolio.
As I mentioned earlier, the company maintains a diversified portfolio and manages its investments under rigorous risk management framework.
Sato
I understand. Thank you very much.
Ito
We will now move on to the next question from Mr. Sasaki from Nomura Securities.
Please go ahead and ask your question.
Sasaki
This is Sasaki from Nomura Securities. I have just one question.
In light of your first-half results, could you share to the extent possible how you currently see the earnings outlook for the next fiscal year? Could you give us some general sense of how we should expect each component to move, including insurance earnings, positive spread, and capital gains and losses?
If you could give us a color to that, that would be appreciated.
Ito
Yes, thank you Mr. Sasaki for your question.
I cannot specifically give you figures, but basically, we expect earnings to grow gradually toward the 2030 group adjusted profit target of ¥230 billion. As for positive spread, we expect it to widen steadily, driven by higher interest rates as well as the benefit of the portfolio replacement.
It's difficult to say how much, but we'd expect positive spread to widen. We also expect insurance earnings to improve as policies in force grow, although with inflation and wage increases, the question is how much we can do to contain costs.
Overall, we aim to grow earnings steadily toward our ¥230 billion target for group adjusted profit for 2030.
Sasaki
Thank you. I have one follow-up question on the replacement of the JGB portfolio.
Do you expect to continue doing this over the next several years, or could it end this fiscal year or the next? At the moment, it looks as though losses on sales of JGBs have offset gains on sales of equities.
Could there come a point when gains on sales of equities boost the earnings?
Ito
Yes, thank you for that question. In short, we plan to continue to rebalance our JGB portfolio on an ongoing basis, we are not working toward an end date in any particular fiscal year.
It's very difficult to predict where the interest rates are headed, we believe we need to spread those replacements out over time.
Sasaki
I see. Thank you very much.
Let us move on to the next question. From Morgan Stanley MUFG Securities, Takemura-san, please go ahead with your question.
Takemura
Thank you very much. I'm Takemura from Morgan Stanley MUFG Securities.
I have two simple questions. My first question concerns T&D Financial Life.
Could you share your assessment of its second quarter results and the outlook going forward? Looking at the three months of the second quarter, adjusted profit was ¥1 billion, which suggests relatively slow progress against your full-year target of ¥8 billion.
Could you explain the reasons behind this and how you expect earnings to catch up? That is my first question.
My second question concerns the pace of equity sale. On slide 24, you explained that the balance of equity holdings had actually increased as of the end of September.
I understand that you have since sold some holdings, and that the balance is expected to decline relative to net assets. However, in absolute terms, the pace of reduction still appears somewhat slow.
Depending on stock market levels, would you consider accelerating the pace of sale at some point?
Thank you for your question, Takemura-san. On T&D Financial Life, there are a couple of reasons why earnings progress was somewhat weak in the second quarter.
One factor was the appreciation of the yen, which required us to strengthen policy reserves for yen-guaranteed riders attached to foreign currency-linked products. We had also two large insurance claims payments.
On the other hand, short-term interest rates, particularly call loan rates, have been rising, and this has steadily improved our positive spread. We expect interest rates, particularly short-term rates, to rise further in the second half.
We anticipate a recovery in earnings during the second half. In the case of T&D Financial Life, cash flows are essentially locked in when new policies are issued.
As a result, earnings are not significantly affected by changes in long-term interest rates. Instead, movements in short-term rates can affect profitability.
Turning to equity sale, we made considerable progress ahead of schedule in the first half, particularly at Daido Life. This was partly supported by favorable stock market conditions, but also reflected the Nürnberger share sale during the first quarter.
Going forward, our policy remains unchanged; we will continue to reduce equity risk by selling shares. Meanwhile, Daido Life's actual progress is slightly below its full-year plan, but we intend to steadily proceed with the sale in the second half.
The scale of disposals in the second half will be determined based on market conditions and other factors. That concludes my response.
Takemura
That was very clear. Thank you very much.
Ito
We will now move on to the next question. Mr.
Sakamaki from Mizuho Securities, please go ahead and ask your question.
Sakamaki
Yes, this is Sakamaki from Mizuho Securities. I have two questions.
My first question is about the second-half investment outlook. Given the first-half results for alternative investments at Taiyo and Daido Life, could you give us a sense of how you see those investments performing in the second half?
My second question is a follow-up on Mr. Takemura's comments about strategic shareholdings on page 24.
One chart shows the end of September balance falling to ¥268.4 billion, while the other figure on the left shows that it's rising to ¥317.2 billion due to the market value changes. To assess your progress, which figure should we look at?
Ito
Yes, thank you Mr. Sakamaki for your question.
As for the second half outlook, alternative earnings are very difficult to forecast because they depend heavily on each individual investment. Both for Taiyo and Daido Life, the return outperformed expectation, but we should not think that it will repeat in the same magnitude for the second half.
At the same time, we do not need to be overly pessimistic, but we are taking a cautious view, but we don't think there is any need to be overly pessimistic. To follow up on your second question, please refer to the chart on the right to measure our progress.
We want to first meet our medium-term target, please look at the figures on the right-hand side to gauge the pace of the progress, because the figure on the left would be affected by fluctuations in the market value, the data points on the right-hand side would be better suited to track the progress.
Sakamaki
Are both charts showing the market value or the fair value?
Ito
I repeat, but we would like you to use the chart on the right to track our progress. Please look at the footnote for the chart on the right.
The figures are based on the market values as of March 31st, 2026, these values are held fixed, we believe this chart is better suited to track the progress on sales.
Sakamaki
I see. That's very clear now.
Thank you very much.
We are approaching the scheduled end time of today's session, the next question will be the last one. Majima-san from Tokai Tokyo Intelligence Lab, please go ahead.
Majima
This is Majima. First, regarding sales of savings-type insurance products at Taiyo Life, at your business briefing around July, I believe you mentioned that Taiyo Life would take a more proactive approach to selling savings-type products.
You explained that employees who have been with Taiyo Life for many years should be quite capable of selling these products, since savings-type products used to account for the majority of their sales. On the other hand, more recent hires have had relatively little experience selling savings-type products, the idea was to expand sales by encouraging these employees to sell such products as well.
That has been my understanding. How is it progressing?
My second question relates to page 7 and 8 of your presentation, which shows the improvement in investment income and expenses, as well as trends in the investment yields. Investment income appears to have recovered quite sharply in the second quarter compared to the first.
Was this primarily due to the cumulative benefits of replacing JGBs, or was it mainly driven by the contribution from alternative assets? Those are my two questions.
Thank you for your question, Majima-san. First, regarding sales of savings-type insurance products, sales activity increased considerably in the second quarter compared to the first.
We are seeing steady progress in encouraging more recent hires to sell these products as well. As for the significant improvement in investment income in the second quarter, the contribution from alternative investments was indeed a major factor.
However, there another contributing factor, namely equity dividends. Interim dividends on equities are recognized in the second quarter, dividend income tends to be higher in that quarter.
That is all. Thank you.
This concludes today's Q&A session. Finally, Ito will deliver a few closing remarks.
Ito
Thank you very much for taking the time to join us today in your busy schedule. Our next Investor Relations event will be an IR briefing on November 27th.
Our president, Moriyama, will discuss our future growth strategy, including progress on our long-term vision. Thank you again for joining us today.
Already premium?